February 2009
Ralph;Feb2009, p8
The article features Lucy, a glamour model who has been posing for "Ralph" discovered at a beach in Australia. It was in 2003 that the pictures of Lucy were published in 2003 and made her famous. According to Lucy, she understand the obsession of men with breasts and that she will remain the best sex guru.


Related Articles

  • BEDROOM BABE. Steiner, Dan // Ralph;Feb2009, p18 

    An interview with Christie Lee Sharpe, an Australian swimwear model, is presented. According to Sharpe, her breasts are 32E which men like. She asserted that sex should have passion especially during kissing and foreplay. She mentioned that she wants to have sex with Josh Duhamel or Daniel Craig...

  • DYNAMIC DUO. Steiner, Dan // Ralph;Mar2010, p56 

    An interview with models Rachel Burr and Rachael Neiberding is presented. They express their opinion about having large breasts and the reaction of other people about their body. They mention their preferred topic in a conversation with men at clubs. When asked about the problems they...

  • Breast Size Not All It's Stacked up to Be. Wilke, Allan J. // Internal Medicine Alert;4/15/2008, Vol. 30 Issue 7, p49 

    The article reports that breast size increase of women at the age of 20 with history of smoking is associated with the risk of diabetes mellitus.

  • Risk of contralateral second primary breast cancer according to hormone receptor status in Germany. Rusner, Carsten; Wolf, Katharina; Bandemer-Greulich, Ulrike; Engel, Jutta; Stegmaier, Christa; Holleczek, Bernd; Schubert-Fritschle, Gabriele; Tillack, Anett; Stang, Andreas // Breast Cancer Research;2014, Vol. 16 Issue 5, p1 

    Introduction Hormone receptor (HR) status has become an established target in treatment strategies of breast cancer. Population-based estimates of contralateral breast cancer (CBC) incidence by HR subtype in particular are limited. The aim of this study was to provide detailed data on CBC...

  • Brachytherapy in breast cancer: an effective alternative. Skowronek, Janusz; Chicheł, Adam // Menopausal Review / Przeglad Menopauzalny;2014, Vol. 13 Issue 1, p48 

    Breast conserving surgery (BCS) with following external beam radiation therapy (EBRT) of the conserved breast has become widely accepted in the last decades for the treatment of early invasive breast cancer. The standard technique of EBRT after BCS is to treat the whole breast up to a total dose...

  • A novel role for ezrin in breast cancer angio/lymphangiogenesis. Ghaffari, Abdi; Hoskin, Victoria; Szeto, Alvin; Hum, Maaike; Liaghati, Navid; Nakatsu, Kanji; Madarnas, Yolanda; SenGupta, Sandip; Elliott, Bruce E. // Breast Cancer Research;2014, Vol. 16 Issue 5, p1 

    Introduction Recent evidence suggests that tumour lymphangiogenesis promotes lymph node metastasis, a major prognostic factor for survival of breast cancer patients. However, signaling mechanisms involved in tumour-induced lymphangiogenesis remain poorly understood. The expression of ezrin, a...

  • Subtype-specific overexpression of the Rac-GEF PREX1 in breast cancer is associated with promoter hypomethylation. Barrio-Real, Laura; Benedetti, Lorena G.; Engel, Nora; Yaping Tu; Soonweng Cho; Sukumar, Saraswati; Kazanietz, Marcelo G. // Breast Cancer Research;2014, Vol. 16 Issue 5, p1 

    Introduction The Rac-GEF P-REX1 is a key mediator of ErbB signaling in breast cancer recently implicated in mammary tumorigenesis and metastatic dissemination. Although P-REX1 is essentially undetectable in normal human mammary epithelial tissue, this Rac-GEF is markedly up-regulated in human...

  • BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Blanchard, Zannel; Paul, Bibbin T.; Craft, Barbara; ElShamy, Wael M. // Breast Cancer Research;2015, Vol. 17 Issue 1, p141 

    Introduction Intrinsic or acquired chemo-resistance is a major problem in oncology. Although highly responsive to chemotherapies such as paclitaxel, most triple negative breast cancers (TNBCs) patients develop chemo-resistance. Here we investigate the role of BRCA1-IRIS as a novel treatment...

  • MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Vilquin, Paul; Donini, Caterina F.; Villedieu, Marie; Grisard, Evelyne; Corbo, Laura; Bachelot, Thomas; Vendrell, Julie A.; Cohen, Pascale A. // Breast Cancer Research;2015, Vol. 17 Issue 1, p202 

    Introduction Increasing evidence indicates micro RNAs (miRNAs) being important players in oncogenesis. Considering the wide-spread use of aromatase inhibitors (AIs) in endocrine therapy as a first-line treatment for post-menopausal endocrine receptor α-positive breast cancer patients,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics